Shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) were up 5.5% during trading on Friday . The company traded as high as $268.86 and last traded at $268.86. Approximately 209,641 shares were traded during trading, a decline of 66% from the average daily volume of 616,241 shares. The stock had previously closed at $254.80.
Direxion Daily S&P Biotech Bull 3x Shares Stock Up 4.2%
The firm’s 50 day moving average price is $218.82 and its two-hundred day moving average price is $187.08.
Institutional Investors Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
A number of institutional investors and hedge funds have recently added to or reduced their stakes in LABU. Squarepoint Ops LLC lifted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.2% in the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock valued at $9,171,000 after purchasing an additional 40,157 shares during the last quarter. Tower Research Capital LLC TRC raised its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 664.7% in the 3rd quarter. Tower Research Capital LLC TRC now owns 58,171 shares of the company’s stock valued at $5,445,000 after buying an additional 50,564 shares during the period. JPMorgan Chase & Co. acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at about $3,208,000. Renaissance Technologies LLC lifted its position in Direxion Daily S&P Biotech Bull 3x Shares by 10.6% in the fourth quarter. Renaissance Technologies LLC now owns 22,900 shares of the company’s stock valued at $3,650,000 after buying an additional 2,200 shares during the last quarter. Finally, Virtu Financial LLC purchased a new position in Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth about $1,757,000.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Read More
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
- Sandisk: What the Chart Is Trying to Tell Us
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
